ABSTRACT

BOTH the World Health Organization and the National Institutes of Health Consensus Development Conference on Late Life Depression have recommended that more clinical trials be conducted in patients over the age of 70 to alleviate the personal and societal burden of depressive illness (1). Although standard treatments have been shown to be efficacious in elderly patients (2) such regimens are often unacceptable to patients or are fraught with side effects in clinical practice (3).